Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

3DWB

structure of human ECE-1 complexed with phosphoramidon

3DWB の概要
エントリーDOI10.2210/pdb3dwb/pdb
関連するPDBエントリー1DMT
関連するBIRD辞書のPRD_IDPRD_000638
分子名称Endothelin-converting enzyme 1, ZINC ION, 5-(2-hydroxyethyl)nonane-1,9-diol, ... (5 entities in total)
機能のキーワードprotein, disease mutation, glycoprotein, hirschsprung disease, hydrolase, membrane, metal-binding, metalloprotease, phosphoprotein, protease, signal-anchor, transmembrane, mch_ece_h_25a1_lt1.pdb
由来する生物種Homo sapiens (Human)
細胞内の位置Cell membrane; Single-pass type II membrane protein: P42892
タンパク質・核酸の鎖数1
化学式量合計77276.17
構造登録者
Oefner, C. (登録日: 2008-07-22, 公開日: 2008-11-25, 最終更新日: 2024-11-20)
主引用文献Schulz, H.,Dale, G.E.,Karimi-Nejad, Y.,Oefner, C.
Structure of human endothelin-converting enzyme I complexed with phosphoramidon
J.Mol.Biol., 385:178-187, 2009
Cited by
PubMed Abstract: Endothelin-converting enzyme I (ECE-1) is a mammalian type II integral membrane zinc-containing endopeptidase. ECE-1 catalyzes the final step in the biosynthesis of endothelins in a rate-limiting fashion, through post-translational conversion of the biologically inactive big endothelins. Endothelin-1 overproduction has been implicated in a heterogeneous list of diseases including systemic and pulmonary hypertension, stroke and asthma, cardiac and renal failure. Therefore, ECE-1 is a prime therapeutic target for the regulation of endothelin-1 production in vivo and there is considerable interest in selective inhibitors of this enzyme. Here, we present the crystal structure of the extracellular domain (residues 90-770) of human ECE-1 (C428S) with the generic metalloprotease inhibitor phosphoramidon determined at 2.38 A resolution. The structure is closely related to that of human NEP, providing essential information for a detailed understanding of ligand-binding, specificity determinants as well as selectivity criteria. Selective inhibitors of ECE-1s should have beneficial effects for the treatment of diseases in which an overproduction of ETs plays a pathogenic role.
PubMed: 18992253
DOI: 10.1016/j.jmb.2008.10.052
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.38 Å)
構造検証レポート
Validation report summary of 3dwb
検証レポート(詳細版)ダウンロードをダウンロード

248942

件を2026-02-11に公開中

PDB statisticsPDBj update infoContact PDBjnumon